SEC Form 5 · accession 0001209191-19-010475
Serina Therapeutics, Inc. · SER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D West
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 14, 2019 · 9:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001708599
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | holding | — | — | — | 17,051 | D |
Table II — derivative securities
No Table II lines on this filing.